FDA Adverse Event Malfunction Summary report: N

INFINITY BIOLOGIX TAQPATH SARS-COV-2 ASSAY

MDR report key: 11593478 · Received March 30, 2021

Report

Report Number
3017938466-2021-00020
Event Type
Malfunction
Date Received
March 30, 2021
Date of Event
October 8, 2020
Report Date
March 30, 2021
Manufacturer
INFINITY BIOLOGIX, LLC
Product Code
QJR
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ORIGINAL TEST DATA REVIEWED AND WAS DETERMINED TO BE CONSISTENT WITH REPORTED RESULT. NO ADDITIONAL ANALYSIS OR INVESTIGATION NEEDED BASED ON DISTRIBUTOR ACTION RECENT LITERATURE HAS DEMONSTRATED THAT SALIVA BASED TESTING METHODS ARE MORE ACCURATE AND MORE SENSITIVE THAN THE NASAL SWAB. REFERENCE: OMER SB, SIMONOV M, WARREN JL, ET AL. SALIVA OR NASOPHARYNGEAL SWAB SPECIMENS FOR DETECTION OF SARS-COV-2. THE NEW ENGLAND JOURNAL OF MEDICINE. 2020;383(13):1283-1286. DOI:10.1056/NEJMC2016359.

Description of Event or Problem · 1

PATIENT TOOK A LABCORP ANTIBODY TEST WHICH CAME BACK NEGATIVE. THIS IS HISTORIC COMPLAINT. SUBMISSION INITIALLY SUBMITTED VIA E-MAIL IN ABSENCE OF EMDR REPORTING NOT SETUP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
490502 INFINITY BIOLOGIX TAQPATH SARS-COV-2 ASSAY TAQPATH SARS-COV-2 ASSAY QJR INFINITY BIOLOGIX, LLC

Patients

Seq Age Sex Outcome Treatment
1